Coverage from the 64th Scientific Sessions of the American College of Cardiology.
Maintaining weight loss offers many health benefits, and a study presented on March 16, 2015, at the 64th Annual Meeting of the American College of Cardiology added another item to the list: obese patients with atrial fibrillation are far more likely to rid themselves of this heart ailment if they shed pounds.
For obese patients, weight loss might require support, as researchers of the LEGACY (Long-Term Effect of Goal-Directed Weight Management on an Atrial Fibrillation Cohort) study concluded. Support is worth providing, because the study found that if patients lost at least 10% of their body weight, they were 6 times more likely to achieve arrhythmiafree survival.
The study, led by Rajeev Pathak, MD, a cardiologist and fellow in electrophysi-ology at the University of Adelaide, Aus-tralia, was the first study to outline the benefits of sustained weight loss, the ef-fects of the amount of weight lost, and the impact of changes in weight over time among patients who suffered from atrial fibrillation (AF). This condition causes shortness of breath and muscle weakness, and can indicate stroke risk. Treatment typically includes anticoagulants, which can present their own risks in some patients.
“We found that sustained weight loss is achievable in obese patients and that it can significantly reduce the burden of atrial fibrillation,” Pathak said. Previous studies had examined only the short-term effects of weight loss on AF.
LEGACY researchers enrolled 355 par-ticipants in a weight loss clinic that pro-vided support through 3 in-person visits a month, nutrition guidance, exercise, counseling and a physical activity diary. All participants were obese (with a body mass index of at least 27 kg/m2) and had AF at the start of the study, and all agreed to participate, which Pathak ac-knowledged does pose some limitations to the results. Subjects with permanent AF, previous AF ablation, and severe medical illnesses were excluded.
Each year for 4 years, participants re-ported for a health exam and an assessment of their AF symptoms, based on their own reports and 7 days’ worth of readings from a Holter monitor. Patients also underwent an echocardiogram and sonogram to measure heart health.
As subjects progressed, they were categorized based on the percentage of body weight lost. Researchers also tracked patients’ AF symptoms, and the results showed that the burden of the condition decreased far more for those who lost the most weight, with both weight loss and weight fluctuation being independent predictors of outcomes. At the 4-year mark, 45% of patients who lost at least 10% of their weight, and 22% of those who lost 3% to 9% of the weight, were free of AF symptoms—without the need for surgery or medication. By con-trast, only 13% of patients who lost less than 3% of their weight were symptom-free without such treatments.
Both sustained weight management and an absence of weight fluctuation were associated with an absence of AF symptoms. Those who lost and regained more than 5% of weight between annu-al visits were twice as likely to experience symptoms. Stable weight loss also helped patients achieve improved blood pressure, cholesterol, and blood sugar levels.
Reference
Pathak R, et al. Long-term effect of goal directed weight management in an atrial fibrillation cohort: A long-term follow-up study (LEGACY Study). J Am Coll Cardiol. doi:101016/jacc.2015.03.002.
Corticosteroid Premedication for Infliximab Remains Unnecessarily Common
July 8th 2025Although use of corticosteroid premedication prior to infliximab infusions is declining, it remains unnecessarily high despite limited benefit and the risk of serious adverse events from corticosteroids.
Read More
Managed Care Reflections: A Q&A With David J. Shulkin, MD
July 7th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The July issue features a conversation with David J. Shulkin, MD, a physician and former secretary of the US Department of Veterans Affairs.
Read More
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More
How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid
June 12th 2025Supported value-based care improves prenatal care while reducing neonatal intensive care unit stays, preterm birth rates, low birth weight rates, and costs for mothers and infants.
Read More